Thus, it is important to investigate whether mutations in the OBSCN gene could cause ARVC, identify its underlying pathogenesis, understand obscurin's function, and find potential therapeutic targets for the management of ARVC. This evidence concerns the gene OBSCN and arrhythmogenic right ventricular cardiomyopathy.